New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.
about
Replication-Competent Influenza A Viruses Expressing Reporter GenesOptimisations and Challenges Involved in the Creation of Various Bioluminescent and Fluorescent Influenza A Virus Strains for In Vitro and In Vivo ApplicationsReplication-competent fluorescent-expressing influenza B virusIdentification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput ScreeningA High Throughput Assay for Screening Host Restriction Factors and Antivirals Targeting Influenza A Virus.Replication-competent influenza A viruses expressing a red fluorescent protein.3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus.Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.Mathematical Model of the Firefly Luciferase Complementation Assay Reveals a Non-Linear Relationship between the Detected Luminescence and the Affinity of the Protein Pair Being AnalyzedReplication-Competent Influenza B Reporter Viruses as Tools for Screening Antivirals and Antibodies.Development and applications of single-cycle infectious influenza A virus (sciIAV).Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development.Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds.Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.Pharmacological Characterization of the Spectrum of Antiviral Activity and Genetic Barrier to Drug Resistance of M2-S31N Channel Blockers.Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.Non-Uniform and Non-Random Binding of Nucleoprotein to Influenza A and B Viral RNA
P2860
Q26746999-4F2AB5FC-6D4A-411B-A76C-FD3D2B91EDFBQ27301941-DCFFBA07-ABF7-4F8F-BE53-1A3ADE784C48Q28387786-63CA959A-FCBD-4609-B34A-19AC4DE7C9ECQ28830304-02889E15-C26C-4028-B3EB-E68B6532CF5DQ30390117-8CCD10B4-D84B-4382-9AAC-DC52BE1A5C4CQ35071285-B4F7329D-51D5-48E9-B347-185121BD2095Q35321520-3E211394-447B-4121-9F5E-2192650E78C4Q35755496-5161FBBD-3855-407D-8A0C-E1553E5EC216Q35926186-6C1FA4F7-E2C5-4D38-8D3B-5D28903B3F4DQ36281137-E627907F-05CF-48A2-9A1D-59F2D9B6D6ACQ38556537-EAA08C4E-53AC-416B-BEBD-12C10921031DQ38641540-ADECF0A5-93E1-4A57-A443-0AEBBB60B90DQ38820461-217DA9E9-8B44-48DA-8ED9-FC003714AEA8Q40051127-57C04F81-0074-472C-B9DD-3D2D205A1EE7Q40094165-754FF2A2-EBA5-4025-9A7D-4B172873B1A3Q40622883-0F416A71-D588-4734-AA58-75C609789C48Q45324307-F0526317-9156-4339-A2E9-DA1C6A0CEF0EQ58696851-9AAC5A7D-CB80-4B19-B3A4-597483DBB9CB
P2860
New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New-generation screening assay ...... ting viral and host functions.
@en
type
label
New-generation screening assay ...... ting viral and host functions.
@en
prefLabel
New-generation screening assay ...... ting viral and host functions.
@en
P2860
P1433
P1476
New-generation screening assay ...... eting viral and host functions
@en
P2093
Grant Beyleveld
Juan Ayllon
P2860
P304
P356
10.1016/J.ANTIVIRAL.2013.07.018
P577
2013-08-06T00:00:00Z